Home » Stocks » BICX

BioCorRx Inc. (BICX)

Stock Price: $1.50 USD -0.03 (-1.96%)
Updated December 4, 2:31 PM EST - Market closed

BICX Stock Price Chart

Key Info

Market Cap 8.13M
Revenue (ttm) 162,847
Net Income (ttm) -3.77M
Shares Out 5.39M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 4
Last Price $1.50
Previous Close $1.53
Change ($) -0.03
Change (%) -1.96%
Day's Open 1.53
Day's Range 1.48 - 1.54
Day's Volume 1,495
52-Week Range 1.48 - 3.50

BICX Stock News

There are no news available yet.

About BICX

BioCorRx, through its subsidiaries, provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers in the United States. It distributes and licenses BioCorRx recovery program, a medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant. The company is also developing BICX101, an injectable naltrexone product; and BICX102, an implantable naltrexone implant for the treatment of alcohol and opioid addiction. It distributes its program to heal... [Read more...]

Industry
Medical Care Facilities
CEO
Brady Granier
Stock Exchange
US OTC
Ticker Symbol
BICX
Full Company Profile

Financial Performance

In 2019, BioCorRx's revenue was $240,259, a decrease of -36.21% compared to the previous year's $376,656. Losses were -$6.04 million, -7.25% less than in 2018.

Financial Statements